Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giorgio Inghirami

Showing results (81-90 of 239) with videos related to

Pageof 24
Sort By:
The Journal of Clinical Investigation|November 18, 2006
Functional validation of the anaplastic lymphoma kinase signature identifies CEBPB and BCL2A1 as critical target genesRoberto Piva, Elisa Pellegrino, Michela Mattioli, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|February 14, 2020
Multiparametric in situ imaging of NPM1-mutated acute myeloid leukemia reveals prognostically-relevant features of the marrow microenvironmentSanjay S Patel, Mikel Lipschitz, Geraldine S Pinkus, et al.
Blood|August 14, 2020
Identification of MALT1 feedback mechanisms enables rational design of potent antilymphoma regimens for ABC-DLBCLLorena Fontan, Rebecca Goldstein, Gabriella Casalena, et al.
Journal of Translational Medicine|May 14, 2013
Comparative analysis of cancer vaccine settings for the selection of an effective protocol in miceFrancesca Kalli, Rodolfo Machiorlatti, Florinda Battaglia, et al.
Oncology Reports|March 8, 2013
Core binding factor acute myeloid leukaemia and c-KIT mutationsLudovica Riera, Filippo Marmont, Daniela Toppino, et al.
Leukemia|July 30, 2024
Tumor evolution analysis uncovered immune-escape related mutations in relapse of diffuse large B-cell lymphomaXueshuai Han, Jingru Sui, Kui Nie, et al.
British Journal of Haematology|July 31, 2024
Targeting CD25+ lymphoma cells with the antibody-drug conjugate camidanlumab tesirine as a single agent or in combination with targeted agentsFilippo Spriano, Chiara Tarantelli, Luciano Cascione, et al.
Genes, Chromosomes & Cancer|December 12, 2013
Molecular events underlying interleukin-6 independence in a subclone of the CMA-03 multiple myeloma cell lineDonata Verdelli, Lucia Nobili, Katia Todoerti, et al.
Pathobiology : Journal of Immunopathology, Molecular and Cellular Biology|March 30, 2023
Primary Effusion Lymphoma in an HIV-Negative Patient with Chronic Myeloid Leukemia Treated with DasatinibIvo N SahBandar, Chandler B Sy, Tayler van den Akker, et al.
Molecular Therapy. Nucleic Acids|October 20, 2018
Aptamer-miR-34c Conjugate Affects Cell Proliferation of Non-Small-Cell Lung Cancer CellsValentina Russo, Alessia Paciocco, Alessandra Affinito, et al.
Pageof 24

Showing results (81-90 of 239) with videos related to

Sort By:
Pageof 24
The Journal of Clinical Investigation|November 18, 2006
Functional validation of the anaplastic lymphoma kinase signature identifies CEBPB and BCL2A1 as critical target genesRoberto Piva, Elisa Pellegrino, Michela Mattioli, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|February 14, 2020
Multiparametric in situ imaging of NPM1-mutated acute myeloid leukemia reveals prognostically-relevant features of the marrow microenvironmentSanjay S Patel, Mikel Lipschitz, Geraldine S Pinkus, et al.
Blood|August 14, 2020
Identification of MALT1 feedback mechanisms enables rational design of potent antilymphoma regimens for ABC-DLBCLLorena Fontan, Rebecca Goldstein, Gabriella Casalena, et al.
Journal of Translational Medicine|May 14, 2013
Comparative analysis of cancer vaccine settings for the selection of an effective protocol in miceFrancesca Kalli, Rodolfo Machiorlatti, Florinda Battaglia, et al.
Oncology Reports|March 8, 2013
Core binding factor acute myeloid leukaemia and c-KIT mutationsLudovica Riera, Filippo Marmont, Daniela Toppino, et al.
Leukemia|July 30, 2024
Tumor evolution analysis uncovered immune-escape related mutations in relapse of diffuse large B-cell lymphomaXueshuai Han, Jingru Sui, Kui Nie, et al.
British Journal of Haematology|July 31, 2024
Targeting CD25+ lymphoma cells with the antibody-drug conjugate camidanlumab tesirine as a single agent or in combination with targeted agentsFilippo Spriano, Chiara Tarantelli, Luciano Cascione, et al.
Genes, Chromosomes & Cancer|December 12, 2013
Molecular events underlying interleukin-6 independence in a subclone of the CMA-03 multiple myeloma cell lineDonata Verdelli, Lucia Nobili, Katia Todoerti, et al.
Pathobiology : Journal of Immunopathology, Molecular and Cellular Biology|March 30, 2023
Primary Effusion Lymphoma in an HIV-Negative Patient with Chronic Myeloid Leukemia Treated with DasatinibIvo N SahBandar, Chandler B Sy, Tayler van den Akker, et al.
Molecular Therapy. Nucleic Acids|October 20, 2018
Aptamer-miR-34c Conjugate Affects Cell Proliferation of Non-Small-Cell Lung Cancer CellsValentina Russo, Alessia Paciocco, Alessandra Affinito, et al.
Pageof 24